9/12/2019 8:05:33 AM
Regulus Announces Publication In Nature Communications Identifying RGLS4326 As Promising Treatment For ADPKD
7/30/2019 8:21:46 AM
Regulus Therapeutics Appoints Cris Calsada As New CFO
6/11/2019 5:01:35 AM
Regulus Therapeutics Names Jake Nunn And Simos Simeonidis To Board
5/8/2019 9:21:14 AM
Wedbush Is Increasing Regulus Therapeutics Inc. (RGLS) FY20 Estimate To -1.09 From -2.11
5/8/2019 9:20:56 AM
Wedbush Is Raising Regulus Therapeutics Inc. (RGLS) Q4 20 Estimate To -0.29 From -0.55
5/8/2019 9:20:43 AM
Wedbush Is Raising Regulus Therapeutics Inc. (RGLS) Q3 20 Estimate To -0.28 From -0.53
5/8/2019 9:20:31 AM
Wedbush Is Raising Regulus Therapeutics Inc. (RGLS) Q2 20 Estimate To -0.27 From -0.52
5/8/2019 9:20:18 AM
Wedbush Is Raising Regulus Therapeutics Inc. (RGLS) Q1 20 Estimate To -0.26 From -0.50
5/8/2019 9:19:56 AM
Wedbush Is Increasing Regulus Therapeutics Inc. (RGLS) FY19 Estimate To -1.41 From -2.09
5/8/2019 9:19:35 AM
Wedbush Is Raising Regulus Therapeutics Inc. (RGLS) Q4 19 Estimate To -0.25 From -0.49
5/8/2019 9:19:21 AM
Wedbush Is Increasing Regulus Therapeutics Inc. (RGLS) Q3 19 Estimate To -0.27 From -0.53
5/8/2019 9:18:57 AM
Wedbush Is Raising Regulus Therapeutics Inc. (RGLS) Q2 19 Estimate To -0.19 From -0.37
5/8/2019 9:18:36 AM
Wedbush Reiterates Regulus Therapeutics Inc. (RGLS) At Neutral With $1 Down From $2 Price Target
5/6/2019 9:17:07 AM
Regulus Therapeutics Enters Amendment With Oxford Finance LLC
3/26/2019 6:50:44 AM
Wedbush Is Increasing Regulus Therapeutics Inc. (RGLS) FY19 Rev. Estimate To 2.6 M From 0.1 M
3/26/2019 6:50:14 AM
Wedbush Is Raising Regulus Therapeutics Inc. (RGLS) FY20 Estimate To -2.11 From -5.70
3/26/2019 6:49:51 AM
Wedbush Is Increasing Regulus Therapeutics Inc. (RGLS) Q4 20 Estimate To -0.55 From -1.50
3/26/2019 6:49:29 AM
Wedbush Is Raising Regulus Therapeutics Inc. (RGLS) Q3 20 Estimate To -0.53 From -1.45
3/26/2019 6:49:17 AM
Wedbush Is Increasing Regulus Therapeutics Inc. (RGLS) Q2 20 Estimate To -0.52 From -1.40